Annual report [Section 13 and 15(d), not S-K Item 405]

Concentrations of Risk

v3.25.1
Concentrations of Risk
12 Months Ended
Dec. 31, 2024
Risks and Uncertainties [Abstract]  
Concentrations of Risk

18. Concentrations of Risk

 

The Company’s revenues are concentrated in a small group of customers with some individually having more than 10% of total revenues.

 

There were no revenues from customers that exceeded 10% of total revenues for the year ended December 31, 2024. The accounts receivable from three customers was 50%, 10% and 22% of the total accounts receivable as of December 31, 2024.

 

Revenues from one customer that exceeded 10% of total revenues for the year ended December 31, 2023, was 20%. The accounts receivable from one customer was 69% of total accounts receivable as of December 31, 2023.

 

 

The Company’s financial instruments that are exposed to concentrations of credit risk consist primarily of cash, cash equivalents and marketable securities. Cash balances are maintained principally at major U.S. financial institutions and are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to regulatory limits. Such cash balances are currently in excess of the FDIC insurance limit of $250 thousand. As of December 31, 2024, the Company did not have any balances that exceeded the FDIC insurance limit. The Company has not experienced any credit losses associated with its cash balances in the past. The Company invests its cash equivalents in U.S. treasury bills with original maturities of three months or less.

 

Marketable securities are comprised of U.S. treasury bills with original maturities greater than three months. The Company has not experienced any losses in such accounts. The Company believes it is not exposed to any significant credit risk on cash, cash equivalents, and marketable securities and performs periodic evaluations of the credit standing of such institutions.